Literature DB >> 31222996

[Progress in epigenetic modification of mRNA and the function of m6A modification].

Haili Gan1, Ling Hong1, Fenglian Yang1, Dingfeng Liu1, Liping Jin1, Qingliang Zheng1.   

Abstract

Messenger RNA (mRNA) can be modified by more than 100 chemical modifications. Among these modifications, N6-methyladenosine (m⁶A) is one of the most prevalent modifications. During the processes of cells differentiation, embryo development or stress, m⁶A can be modified on key mRNAs and regulate the progress of cells through modulating mRNA metabolism and translation. Other mRNA modifications, including N1-methyladenosine (m¹A), 5-methylcytosine (m⁵C) and pseudouridine, together with m⁶A form the epitranscriptome of mRNA that accurately modulate the mRNA translation. Here we review the types and characteristic of mRNA epigenetic modifications, especially the recent progresses of the function of m⁶A, we also expect the main research direction of m⁶A epigenetic modification in the future.

Entities:  

Keywords:  N1-methyladenosine (m1A); N6-methyladenosine (m6A); cell differentiation; epigenetic modification of mRNA; mRNA metabolism; pseudouridine

Mesh:

Substances:

Year:  2019        PMID: 31222996     DOI: 10.13345/j.cjb.180416

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  8 in total

Review 1.  Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.

Authors:  Kun Zhao; Chuan-Xi Yang; Peng Li; Wei Sun; Xiang-Qing Kong
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

2.  FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.

Authors:  Chong Wang; Lingling Li; Mengya Li; Weiqiong Wang; Zhongxing Jiang
Journal:  Cancer Gene Ther       Date:  2022-02-10       Impact factor: 5.987

3.  M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling.

Authors:  Jian-Qing Chen; Yuan-Ping Tao; Yong-Gang Hong; Hui-Fen Li; Zhi-Ping Huang; Xuan-Fu Xu; Hao Zheng; Liang-Kai Hu
Journal:  Cell Cycle       Date:  2021-10-17       Impact factor: 5.173

Review 4.  RNA Methylation in Systemic Lupus Erythematosus.

Authors:  Xinyi Lv; Xiaomin Liu; Ming Zhao; Haijing Wu; Wuiguang Zhang; Qianjin Lu; Xiangmei Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-07

5.  m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning.

Authors:  Maoxin Huang; Yi Zhang; Xiaohong Ou; Caiyun Wang; Xueqing Wang; Bibo Qin; Qiong Zhang; Jie Yu; Jianxiang Zhang; Jianbin Yu
Journal:  J Oncol       Date:  2021-08-04       Impact factor: 4.375

6.  N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.

Authors:  Yibin Zhao; Xiao Yan; Yu Wang; Juan Zhou; Yang Yu
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

7.  METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Yue Zhu; Xinzhi Peng; Qianlei Zhou; Langping Tan; Cheng Zhang; Shaojian Lin; Miaoyun Long
Journal:  Cell Death Dis       Date:  2022-04-18       Impact factor: 9.685

8.  METTL3 Attenuates Inflammation in Fusarium solani-Induced Keratitis via the PI3K/AKT Signaling Pathway.

Authors:  Liwei Huang; Hanfeng Tang; Jianzhang Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.